Moomoo AI 已提取核心信息
Jacob D. Cohen, the Chief Executive Officer of Mangoceuticals, Inc. (MGRX), was reported to have a direct holding of 8,275,000 shares of the company's common stock as of December 28, 2023. The transaction details, including the number of shares acquired or disposed of, the nature of the transaction, and the price per share, were not disclosed. However, the update confirms Cohen's substantial investment in the company, reflecting his ongoing commitment to Mangoceuticals as a key executive.
Jacob D. Cohen, the Chief Executive Officer of Mangoceuticals, Inc. (MGRX), was reported to have a direct holding of 8,275,000 shares of the company's common stock as of December 28, 2023. The transaction details, including the number of shares acquired or disposed of, the nature of the transaction, and the price per share, were not disclosed. However, the update confirms Cohen's substantial investment in the company, reflecting his ongoing commitment to Mangoceuticals as a key executive.
据报道，截至2023年12月28日，Mgrx首席执行官雅各布·科恩直接持有该公司8,27.5万股普通股。交易细节，包括收购或处置的股票数量、交易的性质和每股价格，均未披露。但是，最新消息证实了科恩对该公司的巨额投资，这反映了他作为主要高管对Mangoceuticals的持续承诺。
据报道，截至2023年12月28日，Mgrx首席执行官雅各布·科恩直接持有该公司8,27.5万股普通股。交易细节，包括收购或处置的股票数量、交易的性质和每股价格，均未披露。但是，最新消息证实了科恩对该公司的巨额投资，这反映了他作为主要高管对Mangoceuticals的持续承诺。
有用
没用